This HTML5 document contains 104 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37229239
rdf:type
wikibase:Item
schema:description
wissenschaftlicher Artikel vědecký článek scientific article published on 18 April 2011 vedecký článok مقالة علمية نشرت في 18 أبريل 2011 artigo científico наукова стаття, опублікована у квітні 2011 article scientifique vetenskaplig artikel wetenschappelijk artikel bilimsel makale научни чланак articolo scientifico article científic artículu científicu espublizáu en 2011 videnskabelig artikel
p:P577
wds:Q37229239-ABC411E9-0DB5-47C1-8BF7-5821A6FFBE18
wdt:P577
2011-04-18T00:00:00Z
p:P407
wds:Q37229239-038F0D7F-C522-4A46-9558-FEC659DC1620
wdt:P407
wd:Q1860
p:P2860
wds:Q37229239-48A909CF-12D7-4DE5-9E50-5B1535FA1782 wds:Q37229239-4C8F4B53-42B6-4DD2-A3CB-B78A17DE5265 wds:Q37229239-74ACE8BA-F99C-4D12-9579-1545606F10B6 wds:Q37229239-7C76769F-802A-46AB-A903-7CCCE6636DAC wds:Q37229239-7DDD4FFB-1EC8-4326-946B-A542F67514C3 wds:Q37229239-8BAB63FC-8EB3-4560-8C46-F0535B0F03EC wds:Q37229239-8FC10B0E-3116-4278-B47D-1657A5A13642 wds:Q37229239-A8183A35-569B-4641-B641-794DA49E5084 wds:Q37229239-BF03C039-ADDD-4AA1-AE33-F7E06866B10C wds:Q37229239-042BD87A-6232-4579-86CE-E38910303F9A wds:Q37229239-0456DD1F-61B7-4970-92B9-1825E5C136B7 wds:Q37229239-293004B1-CD4B-45CD-95E3-2A84CD97B9DD wds:Q37229239-34F2066A-172B-48E7-A790-B9CDBD330D28 wds:Q37229239-D9F4CAC9-0958-48C9-A944-4A0B8234F98A wds:Q37229239-DE376153-1EB9-465B-A00C-2C2CABA831FF wds:Q37229239-E5A940B9-D77F-4267-A82B-442EB9E25831 wds:Q37229239-E9610C45-2200-4650-B62B-B5F4AD869D86
wdt:P2860
wd:Q74635505 wd:Q77738544 wd:Q80807888 wd:Q80226586 wd:Q77706014 wd:Q77424043 wd:Q46412803 wd:Q40695838 wd:Q53491085 wd:Q53490056 wd:Q43515558 wd:Q43578938 wd:Q37121698 wd:Q35908993 wd:Q32033905 wd:Q68122887 wd:Q70891272
p:P2093
wds:Q37229239-52951FF5-7109-47E4-8D2C-47D563B4BF6B wds:Q37229239-114E4159-4C63-49FF-A50F-8B41821D98E8 wds:Q37229239-382DD9EA-311F-4169-80DD-68039302F1C4
wdt:P2093
Tsung T Wu Kathryn A Winter Christopher G Willett
rdfs:label
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
skos:prefLabel
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
schema:name
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
p:P50
wds:Q37229239-40518522-0C31-4BD0-AB09-9A1C2DEE319D wds:Q37229239-458B9F6D-64D7-4D05-B7DC-A99AA8CFA788 wds:Q37229239-2D22C15F-C690-437A-A3C6-FDF7CDA5D909 wds:Q37229239-13CD710F-BF50-4876-BD7B-770CF53BEE30 wds:Q37229239-D0CC69AF-77F9-46AE-B476-1F7C68C5DD78
wdt:P50
wd:Q114453614 wd:Q64585410 wd:Q64913003 wd:Q107450763 wd:Q89454225
p:P1476
wds:Q37229239-01D299A5-B710-4DED-9412-F04DB486B67B
wdt:P1476
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
p:P304
wds:Q37229239-8EE33F03-73DA-4F0B-B627-DAC27A39E244
wdt:P304
1967-1972
p:P31
wds:Q37229239-66A90128-EF08-4ACD-BBF2-7E9E10C602D3
wdt:P31
wd:Q13442814
p:P921
wds:Q37229239-8FA7C66F-E984-4699-B2BC-9330CF960610 wds:Q37229239-DF395DC0-792C-4432-AA21-B222FB6BD9EA
wdt:P921
wd:Q372701 wd:Q5090613
p:P698
wds:Q37229239-17B5B774-471F-4EE4-AF70-E93411F7D0E9
wdtn:P698
n9:21507583
wdt:P698
21507583
p:P1433
wds:Q37229239-FED34FFA-7D5A-43F0-B45B-5C6E85A57AD5
wdt:P1433
wd:Q2296252
p:P433
wds:Q37229239-7920BD3A-D7A8-4558-9298-161E0AEBD815
p:P478
wds:Q37229239-6464D6A4-555F-4977-8246-D2E7FDF26509
wdt:P433
5
wdt:P478
82
p:P356
wds:Q37229239-EC2AD26E-5B80-4546-A7DE-D4236541B6D0
wdtn:P356
n11:J.IJROBP.2011.01.043
wdt:P356
10.1016/J.IJROBP.2011.01.043
p:P932
wds:Q37229239-4536ABE3-E855-4229-BF1F-FF268D177452
wdt:P932
3796353